Doubt raised over pomegranate juice anti-prostate cancer claims

NEW PROSTATE CANCER INFOLINK: All that favourable publicity for pomegranate juice and its anti-prostate cancer properties may be in trouble – a US company has been accused of over-selling its benefits. READ MORE>

Read Full Post »

Prostate drug debate: What’s it worth to stay alive a few more months?

WASHINGTON EXAMINER.COM:  Here’s a well-written article on the current US debate about how much a life is worth – more specifically, how much the government Medicare scheme and health insurers pay out for cancer drugs that prolong life for a few months. READ MORE>

Read Full Post »

The confusion about PSA testing that exists between men and their GPs

NEW PROSTATE CANCER INFOLINK: It has been well understood for some time that there is confusion among men in general and among members of the primary care community about appropriate use of PSA testing. READ MORE>

Read Full Post »

Recent research has moved prostate screening debate along

NEW PROSTATE CANCER INFOLINK: The debate about mass screening for prostate cancer has been moved on significantly by by some recent Swedish studies, writes Mike Scott: Is there a simple take-away from these three Swedish studies that correlates to the data from the meta-analysis of the six major screening trials? We believe that there is, and [...]

Read Full Post »

Web-based system enables doctors to better manage prostate cancer treatment

THE ENGINEER: A web-based software system that could help health professionals to manage the treatment of prostate cancer has been developed in the East Midlands. READ MORE> The system will mean that patients with less complex conditions will not have to make repeat trips to hospital, while consultants will have more time to focus on [...]

Read Full Post »

Prostate screening misses out in Obama’s new health insurance

ASSOCIATED PRESS: Screening for prostate cancer will not be included in President Obama’s new preventive health insurance next year. READ MORE> New health insurance policies beginning on or after September 23 must cover — without charge — preventive care that’s backed up by the best scientific evidence. Most people will see this benefit, part of [...]

Read Full Post »

Dear Dr Hutchison and colleagues – here’s some advice

PROSTABLOG NZ:  HERE are four key issues the NZ Parliamentary inquiry into the detection and treatment of prostate cancer ought now to be focusing on: Mass screening…or not: Not. The evidence in favour of mass screening of all middle-aged men for prostate cancer is not sufficiently strong in statistical terms to overcome the counter-arguments concerning [...]

Read Full Post »

Do low-risk prostate cancer patients fully understand potential side effects of surgery?

NEW PROSTATE CANCER INFOLINK:  Men with low-risk prostate cancer who choose surgery need to realise the possible after-effects – reduced urinary and erectile function, shorter penis, penis distortion – they might have to live with for up to 35 years afterwards. READ MORE>

Read Full Post »

Men with low PSA at 60 unlikely to die from prostate cancer

BRITISH MEDICAL JOURNAL: Men with a low PSA score at the age of 60 probably face little risk of dying from prostate cancer – even if they have it already, a new study claims. READ MORE>

Read Full Post »

Big range of ag and garden chemicals linked to prostate cancer

URO TODAY: Canadian researchers have found significant links between prostate cancer and a range of agricultural and gardening chemicals also used at various times in New Zealand. These include DDT, simazine, lindane, dichlone, dinoseb amine, malathion, endosulfan, 2,4-D, 2,4-DB, and carbaryl. READ MORE>

Read Full Post »